Effects of mavacamten on left atrial function in hypertrophic obstructive cardiomyopathy
Benay Özbay(University of Pittsburgh Medical Center), Leyla Elif Sade(University of Pisa), Natarajan Venkatesan(University of Pittsburgh Medical Center), Timothy C. Wong(University of Pittsburgh)
Cited by 1
Related Papers
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
|European Heart Journal|2022|1.1k
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2023|192
Recommendations for the Use of Echocardiography in the Evaluation of Rheumatic Heart Disease: A Report from the American Society of Echocardiography
|Journal of the American Society of Echocardiography|2022|113
Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis
|European Journal of Preventive Cardiology|2023|46
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
|Archives of cardiovascular diseases|2022|38